Status:
UNKNOWN
Transcriptional and Proteomic Analysis of Acute Kidney Injury
Lead Sponsor:
University Hospital Muenster
Conditions:
Acute Kidney Injury
Eligibility:
All Genders
18-150 years
Brief Summary
Acute kidney injury is associated with worsened outcome for critically ill patients. Sepsis-associated and non-septic cardiothoracic surgery associated AKI have been reported, nonetheless, precise pat...
Detailed Description
Acute kidney injury is a common and detrimental finding in critically ill/sepsis patients as well as non-septic patients post cardiothoracic surgery. In many cases renal replacement therapy is require...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- study consent;
- KDIGO\>=2;
- vasoplegia and/or sepsis or elective nephrectomy.
- Exclusion criteria:
- Age\<18 years;
- pregnancy/nursing;
- preexisting CKD with eGFR\<60m/min;
- dialysis; former ogran transplantation;
- HIV; hematologic malignancies;
- immunsuppression;
- 4h post biopsy non-pausable effective anticoagulation;
- pre-existing coagulopathy
Exclusion
Key Trial Info
Start Date :
September 29 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06064305
Start Date
September 29 2023
End Date
December 1 2024
Last Update
October 3 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.